Asia Pacific ePRO, ePatient Diaries, and eCOA Market to Grow at a CAGR of 15.6% to reach US$ 964.2 million from 2021 to 2028

Asia Pacific ePRO, ePatient Diaries, and eCOA Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type of Solution (ECOA (Electronic Clinical Outcome Assessments), EPROs (Patient Reported Outcomes), ClinROs (Clinician Reported Outcomes), ObsROs (Observer Reported Outcomes), PerfOs (Performance Outcomes), and ePatient Diaries); Modality (Computer, and Mobile Devices (Smartphones and Tablets)); End User (Clinical Trial Sponsors, Contract Research Organizations (CRO’s), Hospitals, Academic Institutes, Pharmaceutical Companies, and Others)

  • Report Code : TIPRE00022816
  • Category : Healthcare IT
  • Status : Published
  • No. of Pages : 148
Buy Now

The ePRO, ePatient Diaries, and eCOA market in Asia Pacific is expected to grow from US$ 348.8 million in 2021 to US$ 964.2 million by 2028; it is estimated to grow at a CAGR of 15.6% from 2021 to 2028.



With an increase in clinical trials and the need to be able to easily centralize data capture, as well as the need to drive down the overall cost of bringing a new drug to market, the adoption of ePRO, e-Patient Diaries, and eCOA platforms will be on rise as capturing data using eCOA solutions not only improves the quality of data, but also complements the data collection process across the study, leading to reduced risk and providing significant value. Additionally, majority of clinical trial stakeholders including sponsors, CROs and regulators consider eCOA as the most effective way to capture high-quality and more reliable data than traditional, paper-based methods.

The DIA China Digital Health Community organized a series of Remote Digital Clinical Trials During COVID-19 Pandemic online seminars to increase global interest in remote clinical trials and digital clinical trial resources. Veteran clinicians and researchers presented real-life examples of remote clinical trial and digital trial technology implementations in China and strategies and plans based on their experiences. Sponsors and CROs have been able to preserve their business continuity in China by using remote clinical trials to overcome the difficulties of conducting conventional clinical trials faced by the COVID-19 pandemic (impacting on-site subject visits, data monitoring, and drug delivery). However, since these trials are just getting underway in China, it's important to optimize the effect of these technologies and services, and relevant regulations should evolve to support these developments accordingly. Thus, ePRO, e-Patient Diaries, and eCOA market is moderately impacted due to COVID -19.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the ePRO, ePatient Diaries, and eCOA market. The Asia Pacific ePRO, ePatient Diaries, and eCOA market is expected to grow at a good CAGR during the forecast period.


  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

Asia Pacific EPRO, ePatient Diaries, and eCOA Market Segmentation  

By Type of Solution

  • eClinical Outcome Assessments
  • e-Patient Reported Outcomes
  • Clinician Reported Outcomes
  • Observer Reported Outcomes
  • Performance Outcomes
  • e-Patient Diaries

By Modality

  • Computer
  • Mobile Devices

By End User

  • Clinical Trial Sponsors
  • Contract Research Organizations
  • Hospitals
  • Academic Institutes
  • Pharmaceutical Companies
  • Others

By Country

  • Asia Pacific

    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia Pacific

Companies Mentioned

  1. ERT Clinical     
  2. ArisGlobal LLC          
  3. The Diary Pte. Ltd      
  4. ICON PLC       
  5. PAREXEL INTERNATIONAL CORPORATION   
  6. Anju Software, Inc.    
  7. Kayentis        
  8. Bracket Global LLC     
  9. Dassault Systèmes SE          
  10. CRF Health     
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Type of Solution, Modality , End User

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

Australia, China, Japan, South Korea

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 ePRO, ePatient Diaries, and eCOA Market – By Type of Solution

1.3.2 ePRO, ePatient Diaries, and eCOA Market – By Modality

1.3.3 ePRO, ePatient Diaries, and eCOA Market – By End User

1.3.4 Asia Pacific ePRO, ePatient Diaries, and eCOA Market – By Country

2. Asia Pacific ePRO, ePatient Diaries, and eCOA Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Asia Pacific ePRO, ePatient Diaries, and eCOA Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 ePRO, ePatient Diaries, and eCOA Market- Asia Pacific PEST Analysis

4.3 Expert Opinion

5. Asia Pacific ePRO, ePatient Diaries, and eCOA Market - Key Market Dynamics

5.1 Market Drivers

5.1.1 Increasing Demand for Electronic Health Records (EHRs)

5.1.2 Rising Use of Smartphones

5.1.3 Growing Demand for Clinical Trials

5.2 Market Restraints

5.2.1 Concerns Regarding Data Privacy

5.3 Market Opportunities

5.3.1 Growing Healthcare IT Industry in Emerging Economies

5.4 Future Trends

5.4.1 Rise of Patient-Centric Practices

5.5 Impact Analysis

6. ePRO, ePatient Diaries, and eCOA Market – Asia Pacific Analysis

6.1 Asia Pacific ePRO, ePatient Diaries, and eCOA Market Revenue Forecasts and Analysis

7. Asia Pacific ePRO, ePatient Diaries, and eCOA Market Analysis and Forecasts To 2028 – By Type of Solution

7.1 Overview

7.2 ePRO, e-Patient Diaries, and eCOA Market Share, by Type of Solution, 2020 and 2028 (%)

7.3 eCOA (ELECTRONIC CLINICAL OUTCOME ASSESSMENTS)

7.3.1 Overview

7.3.2 eCOA: ePRO, e-Patient Diaries, and eCOA Market– Revenue and Forecast to 2028 (USD Million)

7.4 ePROs (PATIENT REPORTED OUTCOMES)

7.4.1 Overview

7.4.2 ePRO: ePRO, e-Patient Diaries, and eCOA Market– Revenue and Forecast to 2028 (USD Million)

7.5 ClinROs (CLINICIAN REPORTED OUTCOMES)

7.5.1 Overview

7.5.2 ClinROs: ePRO, e-Patient Diaries, and eCOA Market– Revenue and Forecast to 2028 (USD Million)

7.6 ObsROs (OBSERVER REPORTED OUTCOMES)

7.6.1 Overview

7.6.2 ObsROs: ePRO, e-Patient Diaries, and eCOA Market– Revenue and Forecast to 2028 (USD Million)

7.7 PerfOs (PERFORMANCE OUTCOMES)

7.7.1 Overview

7.7.2 PerfOs: ePRO, e-Patient Diaries, and eCOA Market– Revenue and Forecast to 2028 (USD Million)

7.8 E-PATIENT DIARIES

7.8.1 Overview

7.8.2 E-Patient Diaries: ePRO, e-Patient Diaries, and eCOA Market– Revenue and Forecast to 2028 (USD Million)

8. Asia Pacific ePRO, ePatient Diaries, and eCOA Market Analysis and Forecasts To 2028 – By Modality

8.1 Overview

8.2 ePRO, e-Patient Diaries, and eCOA Market Share, by Modality, 2020 and 2028 (%)

8.3 Computer

8.3.1 Overview

8.3.2 Computer: ePRO, e-Patient Diaries, and eCOA Market– Revenue and Forecast to 2028 (USD Million)

8.4 MOBILE DEVICES (SMARTPHONES AND TABLETS)

8.4.1 Overview

8.4.2 Mobile Devices: ePRO, e-Patient Diaries, and eCOA Market– Revenue and Forecast to 2028 (USD Million)

9. Asia Pacific ePRO, ePatient Diaries, and eCOA Market Analysis and Forecasts to 2028– By End User

9.1 Overview

9.2 ePRO, e-Patient Diaries, and eCOA Market Share, by End User, 2020 and 2028 (%)

9.3 CLINICAL TRIAL SPONSORS

9.3.1 Overview

9.3.2 Clinical Trial Sponsors: ePRO, e-Patient Diaries, and eCOA Market– Revenue and Forecast to 2028(USD Million)

9.4 CONTRACT RESEARCH ORGANIZATIONS (CROs)

9.4.1 Overview

9.4.2 Contract Research Organizations: ePRO, e-Patient Diaries, and eCOA Market– Revenue and Forecast to 2028 (USD Million)

9.5 HOSPITALS

9.5.1 Overview

9.5.2 Hospitals: ePRO, e-Patient Diaries, and eCOA Market– Revenue and Forecast to 2028 (USD Million)

9.6 Academic Institutes

9.6.1 Overview

9.6.2 Academic Institutes: ePRO, e-Patient Diaries, and eCOA Market– Revenue and Forecast to 2028 (USD Million)

9.7 Pharmaceutical Companies

9.7.1 Overview

9.7.2 Pharmaceutical Companies: ePRO, e-Patient Diaries, and eCOA Market– Revenue and Forecast to 2028 (USD Million)

9.8 Others

9.8.1 Overview

9.8.2 Others: ePRO, e-Patient Diaries, and eCOA Market– Revenue and Forecast to 2028 (USD Million)

10. ePRO, ePatient Diaries, and eCOA Market Revenue and Forecasts to 2028 – Geographical Analysis

10.1 Asia Pacific: ePRO, e-Patient Diaries, and eCOA Market

10.1.1 Overview

10.1.2 Asia-Pacific: ePRO, e-Patient Diaries, and eCOA Market, by Country, 2020 & 2028 (%)

10.1.2.1 China: ePRO, e-Patient Diaries, and eCOA Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.1 China: ePRO, e-Patient Diaries, and eCOA Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.2 China: ePRO, e-Patient Diaries, and eCOA Market, by Type of Solution, 2019–2028 (USD Million)

10.1.2.1.3 China: ePRO, e-Patient Diaries, and eCOA Market, by Modality, 2019–2028 (USD Million)

10.1.2.1.4 China: ePRO, e-Patient Diaries, and eCOA Market, by End User, 2019–2028 (USD Million)

10.1.2.2 Japan: ePRO, e-Patient Diaries, and eCOA Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.1 Japan: ePRO, e-Patient Diaries, and eCOA Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.2 Japan: ePRO, e-Patient Diaries, and eCOA Market, by Type of Solution, 2019–2028 (USD Million)

10.1.2.2.3 Japan: ePRO, e-Patient Diaries, and eCOA Market, by Modality, 2019–2028 (USD Million)

10.1.2.2.4 Japan: ePRO, e-Patient Diaries, and eCOA Market, by End User, 2019–2028 (USD Million)

10.1.2.3 India: ePRO, e-Patient Diaries, and eCOA Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.1 India: ePRO, e-Patient Diaries, and eCOA Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.2 India: ePRO, e-Patient Diaries, and eCOA Market, by Type of Solution, 2019–2028 (USD Million)

10.1.2.3.3 India: ePRO, e-Patient Diaries, and eCOA Market, by Modality, 2019–2028 (USD Million)

10.1.2.3.4 India: ePRO, e-Patient Diaries, and eCOA Market, by End User, 2019–2028 (USD Million)

10.1.2.4 Australia: ePRO, e-Patient Diaries, and eCOA Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.4.1 Australia: ePRO, e-Patient Diaries, and eCOA Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.4.2 Australia: ePRO, e-Patient Diaries, and eCOA Market, by Type of Solution, 2019–2028 (USD Million)

10.1.2.4.3 Australia: ePRO, e-Patient Diaries, and eCOA Market, by Modality, 2019–2028 (USD Million)

10.1.2.4.4 Australia: ePRO, e-Patient Diaries, and eCOA Market, by End User, 2019–2028 (USD Million)

10.1.2.5 South Korea: ePRO, e-Patient Diaries, and eCOA Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.5.1 South Korea: ePRO, e-Patient Diaries, and eCOA Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.5.2 South Korea: ePRO, e-Patient Diaries, and eCOA Market, by Type of Solution, 2019–2028 (USD Million)

10.1.2.5.3 South Korea: ePRO, e-Patient Diaries, and eCOA Market, by Modality, 2019–2028 (USD Million)

10.1.2.5.4 South Korea: ePRO, e-Patient Diaries, and eCOA Market, by End User, 2019–2028 (USD Million)

10.1.2.6 Rest of Asia-Pacific: ePRO, e-Patient Diaries, and eCOA Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.6.1 Rest of Asia-Pacific: ePRO, e-Patient Diaries, and eCOA Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.6.2 Rest of Asia-Pacific: ePRO, e-Patient Diaries, and eCOA Market, by Type of Solution, 2019–2028 (USD Million)

10.1.2.6.3 Rest of Asia-Pacific: ePRO, e-Patient Diaries, and eCOA Market, by Modality, 2019–2028 (USD Million)

10.1.2.6.4 Rest of Asia-Pacific: ePRO, e-Patient Diaries, and eCOA Market, by End User, 2019–2028 (USD Million)

11. Impact Of COVID-19 Pandemic on Asia Pacific ePRO, ePatient Diaries, and eCOA Market

11.1 Asia Pacific: Impact Assessment of COVID-19 Pandemic

12. Industry Landscape

12.1 Overview

12.2 Growth Strategies Done by the Companies in the Market, (%)

12.3 Organic Developments

12.3.1 Overview

12.4 Inorganic Developments

12.4.1 Overview

13. COMPANY PROFILES

13.1 ERT Clinical

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 ArisGlobal LLC

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 The Diary Pte. Ltd

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 ICON PLC

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 PAREXEL INTERNATIONAL CORPORATION

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 OmniComm Systems, Inc. (Anju Software, Inc.)

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Kayentis

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 Bracket Global LLC (Signant Health)

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 Medidata Solutions (Dassault Systemes SE)

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

13.10 CRF Health (Signant Health)

13.10.1 Key Facts

13.10.2 Business Description

13.10.3 Products and Services

13.10.4 Financial Overview

13.10.5 SWOT Analysis

13.10.6 Key Developments

14. Appendix

14.1 About the Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. China: ePRO, e-Patient Diaries, and eCOA Market, by Type of Solution – Revenue and Forecast to 2028(USD Million)

Table 2. China: ePRO, e-Patient Diaries, and eCOA Market, by Modality – Revenue and Forecast to 2028 (USD Million)

Table 3. China: ePRO, e-Patient Diaries, and eCOA Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 4. Japan: ePRO, e-Patient Diaries, and eCOA Market, by Type of Solution – Revenue and Forecast to 2028 (USD Million)

Table 5. Japan: ePRO, e-Patient Diaries, and eCOA Market, by Modality – Revenue and Forecast to 2028 (USD Million)

Table 6. Japan: ePRO, e-Patient Diaries, and eCOA Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 7. India: ePRO, e-Patient Diaries, and eCOA Market, by Type of Solution – Revenue and Forecast to 2028 (USD Million)

Table 8. India: ePRO, e-Patient Diaries, and eCOA Market, by Modality – Revenue and Forecast to 2028 (USD Million)

Table 9. India: ePRO, e-Patient Diaries, and eCOA Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 10. Australia: ePRO, e-Patient Diaries, and eCOA Market, by Type of Solution – Revenue and Forecast to 2028 (USD Million)

Table 11. Australia: ePRO, e-Patient Diaries, and eCOA Market, by Modality – Revenue and Forecast to 2028 (USD Million)

Table 12. Australia: ePRO, e-Patient Diaries, and eCOA Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 13. South Korea: ePRO, e-Patient Diaries, and eCOA Market, by Type of Solution – Revenue and Forecast to 2028 (USD Million)

Table 14. South Korea: ePRO, e-Patient Diaries, and eCOA Market, by Modality – Revenue and Forecast to 2028 (USD Million)

Table 15. South Korea: ePRO, e-Patient Diaries, and eCOA Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 16. Rest of Asia-Pacific: ePRO, e-Patient Diaries, and eCOA Market, by Type of Solution – Revenue and Forecast to 2028 (USD Million)

Table 17. Rest of Asia-Pacific: ePRO, e-Patient Diaries, and eCOA Market, by Modality – Revenue and Forecast to 2028 (USD Million)

Table 18. Rest of Asia-Pacific: ePRO, e-Patient Diaries, and eCOA Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 19. Organic Developments Done by Companies

Table 20. Inorganic Developments Done by Companies

Table 21. Glossary of Terms, ePRO, ePatient Diaries, and eCOA Market

LIST OF FIGURES

Figure 1. ePRO, ePatient Diaries, and eCOA Market Segmentation

Figure 2. Asia Pacific ePRO, ePatient Diaries, and eCOA Market Overview

Figure 3. e-Clinical Outcome Assessments Segment Held Largest Share of Type of Solution in ePRO, ePatient Diaries, and eCOA Market

Figure 4. India is Expected to Show Remarkable Growth During the Forecast Period

Figure 5. ePRO, ePatient Diaries, and eCOA Market - Asia Pacific PEST Analysis

Figure 6. ePRO, ePatient Diaries, and eCOA Market Impact Analysis of Driver and Restraints

Figure 7. Asia Pacific ePRO, ePatient Diaries, and eCOA Market – Revenue Forecasts and Analysis – 2020- 2028

Figure 1. ePRO, e-Patient Diaries, and eCOA Market Share, by Type of Solution, 2020 and 2028 (%)

Figure 2. eCOA: ePRO, e-Patient Diaries, and eCOA Market– Revenue and Forecast to 2028 (USD Million)

Figure 3. ePRO: ePRO, e-Patient Diaries, and eCOA Market– Revenue and Forecast to 2028 (USD Million)

Figure 4. ClinROs: ePRO, e-Patient Diaries, and eCOA Market– Revenue and Forecast to 2028 (USD Million)

Figure 5. ObsROs: ePRO, e-Patient Diaries, and eCOA Market– Revenue and Forecast to 2028 (USD Million)

Figure 6. PerfOs: ePRO, e-Patient Diaries, and eCOA Market– Revenue and Forecast to 2028 (USD Million)

Figure 7. E-Patient Diaries: ePRO, e-Patient Diaries, and eCOA Market– Revenue and Forecast to 2028 (USD Million)

Figure 8. ePRO, e-Patient Diaries, and eCOA Market Share, by Modality, 2020 and 2028 (%)

Figure 9. Computer: ePRO, e-Patient Diaries, and eCOA Market– Revenue and Forecast to 2028 (USD Million)

Figure 10. Mobile Devices: ePRO, e-Patient Diaries, and eCOA Market– Revenue and Forecast to 2028 (USD Million)

Figure 11. ePRO, e-Patient Diaries, and eCOA Market Share, by End User, 2020 and 2028 (%)

Figure 12. Clinical Trial Sponsors: ePRO, e-Patient Diaries, and eCOA Market– Revenue and Forecast to 2028 (USD Million)

Figure 13. Contract Research Organizations: ePRO, e-Patient Diaries, and eCOA Market– Revenue and Forecast to 2028 (USD Million)

Figure 14. Hospitals: ePRO, e-Patient Diaries, and eCOA Market– Revenue and Forecast to 2028 (USD Million)

Figure 15. Academic Institutes: ePRO, e-Patient Diaries, and eCOA Market– Revenue and Forecast to 2028 (USD Million)

Figure 16. Pharmaceutical Companies: ePRO, e-Patient Diaries, and eCOA Market– Revenue and Forecast to 2028 (USD Million)

Figure 17. Others: ePRO, e-Patient Diaries, and eCOA Market– Revenue and Forecast to 2028 (USD Million)

Figure 18. Asia-Pacific: ePRO, e-Patient Diaries, and eCOA Market, by Key Country – Revenue (2020) (USD Million)

Figure 19. Asia-Pacific: ePRO, e-Patient Diaries, and eCOA Market, by Country, 2020 & 2028 (%)

Figure 20. China: ePRO, e-Patient Diaries, and eCOA Market – Revenue and Forecast to 2028 (USD Million)

Figure 21. Japan: ePRO, e-Patient Diaries, and eCOA Market – Revenue and Forecast to 2028 (USD Million)

Figure 22. India: ePRO, e-Patient Diaries, and eCOA Market – Revenue and Forecast to 2028 (USD Million)

Figure 23. Australia: ePRO, e-Patient Diaries, and eCOA Market – Revenue and Forecast to 2028 (USD Million)

Figure 24. South Korea: ePRO, e-Patient Diaries, and eCOA Market – Revenue and Forecast to 2028 (USD Million)

Figure 25. Rest of Asia-Pacific: ePRO, e-Patient Diaries, and eCOA Market – Revenue and Forecast to 2028 (USD Million)

Figure 26. Impact of COVID-19 Pandemic in Asia Pacific Country Markets

Figure 27. Growth Strategies Done by the Companies in the Market, (%)

  1. ERT Clinical             
  2. ArisGlobal LLC       
  3. The Diary Pte. Ltd                
  4. ICON PLC                
  5. PAREXEL INTERNATIONAL CORPORATION   
  6. Anju Software, Inc.             
  7. Kayentis                  
  8. Bracket Global LLC              
  9. Dassault Systèmes SE        
  10. CRF Health             

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Asia Pacific ePRO, ePatient Diaries, and eCOA Market